Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Gross Margin (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Gross Margin for 16 consecutive years, with 66.13% as the latest value for Q3 2025.

  • Quarterly Gross Margin rose 776.0% to 66.13% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 62.02% through Sep 2025, up 114.0% year-over-year, with the annual reading at 58.17% for FY2024, 258.0% down from the prior year.
  • Gross Margin for Q3 2025 was 66.13% at Xtant Medical Holdings, down from 68.58% in the prior quarter.
  • The five-year high for Gross Margin was 68.58% in Q2 2025, with the low at 50.85% in Q4 2024.
  • Average Gross Margin over 5 years is 59.47%, with a median of 60.97% recorded in 2023.
  • The sharpest move saw Gross Margin crashed -1396bps in 2021, then surged 776bps in 2025.
  • Over 5 years, Gross Margin stood at 55.15% in 2021, then fell by -1bps to 54.39% in 2022, then increased by 12bps to 60.97% in 2023, then decreased by -17bps to 50.85% in 2024, then soared by 30bps to 66.13% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 66.13%, 68.58%, and 61.52% for Q3 2025, Q2 2025, and Q1 2025 respectively.